Alizaprid Садржај Osobine Reference Literatura Spoljašnje veze Мени за навигацијуMonografija59338-93-1WHO43008DB0142539202CHEMBL2901943048762„DrugBank 3.0: a comprehensive resource for omics research on drugs”30137092105968210.1093/nar/gkq1126„DrugBank: a knowledgebase for drugs, drug actions and drug targets”22388891804841210.1093/nar/gkm958„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”10.1021/jp980230o„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”1174957310.1021/ci000392t„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”1102028610.1021/jm000942eGoodman & Gilman's The Pharmacological Basis of Therapeutics10.1036/0071422803Foye's Principles of Medicinal ChemistryAlizapridVikimedijinoj ostaviAlizaprideу
АнтиеметициСтимуланси мотилитетаАцетамидиЕтриПиролидини
organsko jedinjenjeatomaugljenikamolekulsku masuDaMDIGtgpphysdevpenzynococongtumrsysieponprocdrugA2A2B345671416blte
(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУчествуј у u003Cbu003Eu003Ca href="https://meta.wikimedia.org/wiki/%D0%92%D0%B5%D0%BB%D0%B8%D0%BA%D0%BE_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%BD%D0%BE_%D1%81%D1%80%D0%B5%D1%92%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%9E%D1%81%D1%82%D0%B0%D0%B2%D0%B5" class="extiw" title="meta:Велико пролећно сређивање Оставе"u003EВеликом пролећном сређивању Оставеu003C/au003Eu003C/bu003E од 15. марта до 15. априла!u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EТакмичи се у писању u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eчланака о средњој и источној Европиu003C/au003Eu003C/bu003E од 21. марта до 31. маја!u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУ току су расправе о u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%A3%D0%B2%D0%BE%D1%92%D0%B5%D1%9A%D0%B5_%D0%BE%D0%BF%D1%88%D1%82%D0%B5_%D0%BF%D1%80%D0%B8%D0%BF%D1%80%D0%B5%D0%BC%D0%B5" title="Википедија:Гласање/Предлог/Увођење опште припреме"u003Eувођењу опште припремеu003C/au003Eu003C/bu003E и u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%9F%D1%80%D0%B0%D0%B2%D0%BE_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%BE%D1%80_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D1%84%D0%B5%D1%98%D1%81%D0%B0" title="Википедија:Гласање/Предлог/Право администратор интерфејса"u003Eадминистраторима интерфејсаu003C/au003Eu003C/bu003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУ току је гласање о u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D0%BE%D0%B2%D0%B5%D1%9B%D0%B0%D1%9A%D0%B5_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%B7%D0%B0_%D1%81%D0%BB%D0%B8%D0%BA%D0%B5_%D0%BD%D0%B0_%D0%B3%D0%BB%D0%B0%D0%B2%D0%BD%D0%BE%D1%98_%D1%81%D1%82%D1%80%D0%B0%D0%BD%D0%B8" title="Википедија:Гласање/Повећање простора за слике на главној страни"u003Eповећању простора за слике на Главној страниu003C/au003Eu003C/bu003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());
Alizaprid
Иди на навигацију
Иди на претрагу
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | Limican, Liticum |
| Drugs.com | Monografija |
Farmakokinetički podaci | |
| Poluvreme eliminacije | 3 h |
| Izlučivanje | Renalno |
| Identifikatori | |
| CAS broj | 59338-93-1  Y |
| ATC kod | A03FA05 (WHO) |
| PubChem | CID 43008 |
| DrugBank | DB01425 Y |
| ChemSpider | 39202 Y |
| ChEMBL | CHEMBL290194 Y |
| Hemijski podaci | |
| Formula | C16H21N5O2 |
| Molarna masa | 315,370 |
SMILES
| |
InChI
| |
| Fizički podaci | |
| Tačka topljenja | 139 °C (282 °F) |
Alizaprid je organsko jedinjenje, koje sadrži 16 atoma ugljenika i ima molekulsku masu od 315,370 Da.[1][2][3]
Садржај
1 Osobine
2 Reference
3 Literatura
4 Spoljašnje veze
Osobine
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 5 |
| Broj donora vodonika | 2 |
| Broj rotacionih veza | 6 |
Particioni koeficijent[4] (ALogP) | 1,8 |
Rastvorljivost[5] (logS, log(mol/L)) | -2,8 |
Polarna površina[6] (PSA, Å2) | 83,1 |
Reference
^ Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20. PMID 3048762
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889. PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
 | Alizaprid na Vikimedijinoj ostavi. |
- Alizapride
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Категорије:
- Антиеметици
- Стимуланси мотилитета
- Ацетамиди
- Етри
- Пиролидини
(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.644","walltime":"0.800","ppvisitednodes":"value":4129,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":123416,"limit":2097152,"templateargumentsize":"value":6375,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":10664,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 690.092 1 -total"," 52.23% 360.464 4 Шаблон:Infobox"," 47.24% 325.991 1 Шаблон:Drugbox-lat"," 25.64% 176.941 1 Шаблон:Reflist"," 19.84% 136.938 5 Шаблон:Cite_journal"," 19.22% 132.655 4 Шаблон:Cite_pmid"," 10.31% 71.165 1 Шаблон:Commonscat-lat"," 10.16% 70.114 1 Шаблон:Cite_pmid/21059682"," 6.40% 44.168 1 Шаблон:Infobox_drug-lat/chemical_formula"," 5.16% 35.614 1 Шаблон:Convert-lat"],"scribunto":"limitreport-timeusage":"value":"0.266","limit":"10.000","limitreport-memusage":"value":6040104,"limit":52428800,"cachereport":"origin":"mw1302","timestamp":"20190405192016","ttl":2592000,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"Alizaprid","url":"https://sr.wikipedia.org/wiki/Alizaprid","sameAs":"http://www.wikidata.org/entity/Q631829","mainEntity":"http://www.wikidata.org/entity/Q631829","author":"@type":"Organization","name":"u0421u0430u0440u0430u0434u043du0438u0446u0438 u043fu0440u043eu0458u0435u043au0430u0442u0430 u0412u0438u043au0438u043cu0435u0434u0438u0458u0435","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2013-12-19T00:04:27Z","dateModified":"2017-01-04T06:11:46Z","image":"https://upload.wikimedia.org/wikipedia/commons/5/52/Alizapride.svg"(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgBackendResponseTime":124,"wgHostname":"mw1270"););
